Brazil signs letter of intent to purchase five COVID vaccines By


© . FILE PHOTO: Outbreak of the coronavirus disease (COVID-19), in Brazil

BRASILIA () – Brazil’s health ministry said on Sunday it will sign non-binding letters of intent to purchase coronavirus vaccines from four companies and Russia’s sovereign wealth fund, adding that any purchase will depend on the approval of the nation’s regulators.

According to the ministry, officials met last week with representatives of Pfizer Inc (NYSE:), India’s Bharat Biotech, the Russian Direct Investment Fund, Moderna (NASDAQ:) Inc and Janssen, a unit of Johnson & Johnson (NYSE:).

In a statement, the ministry said its legal and technical departments were analyzing the documents presented by the five entities and determining the best way to go about purchasing vaccines at “the opportune moment.”

The government has contracts in place to guarantee access to 142,900,000 coronavirus vaccine doses, enough to immunize at least a third of Brazil’s population, officials said in the statement.

So far, the Brazilian federal government’s main bet is on a vaccine being developed by AstraZeneca (NASDAQ:) PLC, with which it has already signed a supply contract.

In Sao Paulo, Brazil’s largest state, local authorities have signed a deal with China’s Sinovac Biotech Ltd to test and produce a vaccine locally. Brazilian President Jair Bolsonaro, a long-time critic of China, has dismissed that vaccine as untrustworthy, without presenting evidence.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.